Results 121 to 130 of about 11,480 (212)

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2001
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj  

Antiagregantes plaquetarios: mecanismos de acción y riesgos asociados al uso Platelet antiaggregants: mechanisms of action and use asocied risks

Vitae, 2009
Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G, Constanza I TORRES U, Rodrigo E MOORE-CARRASCO, Marcelo A ALARCÓN L, Patricio J MARAGAÑO L   +4 more
doaj  

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score [PDF]

, 2017
Background The SYNTAX score (SXscore), an anatomical-based scoring tool reflecting the complexity of coronary anatomy, has established itself as an important long-term prognostic factor in patients undergoing percutaneous coronary intervention (PCI). The
Dawkins, Keith D., de Vries, Ton, Diletti, Roberto, Farooq, Vasim, Garcia-Garcia, Hector, Kappetein, Arie Pieter, Morel, Marie Angèle, Räber, Lorenz, Serruys, Patrick W., Steyerberg, Ewout W., Swart, Michael, Valgimigli, Marco, Vergouwe, Yvonne, Vranckx, Pascal, Windecker, Stephan   +14 more
core  

CD2: ABCIXIMAB IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A MULTICENTER OBSERVATIONAL STUDY

, 1999
Vlasses Ph, C Chen, Harlan Krumholz, Douglas Cocks, David M. McGee, D. B. Morton   +5 more
openalex   +1 more source

Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome

, 2014
Muhammad Tariq Shakoor, Samia Ayub, Sajid Dhakam   +2 more
openalex   +1 more source

Non-traumatic spinal intradural haematoma: a rare case of paralysis following abciximab for ST elevation acute coronary syndrome [PDF]

, 2016
G. Wong, D. Scherer, Adam J. Nelson, M. Worthley   +3 more
openalex   +1 more source

Evaluation of Abciximab on Dissolution of Newly Formed Thrombus Developed During Coronary Angioplasty and Stenting

, 2022
CHUAN-YU GAO, ROBERT WHITBOURN
openalex   +2 more sources

Benefits of abciximab for patients with ischemic stroke [PDF]

, 2005
Claire Braybrook
openalex   +1 more source

A Longitudinal Analysis of Outcomes Associated with Abciximab and Eptifibatide in a Consecutive Series of 3074 Percutaneous Coronary Interventions

, 2007
Kirsten Hall Long, Henry H. Ting, Erin K. McMurtry, Ryan J. Lennon, Douglas L. Wood, David R. Holmes, Ganesh Raveendran, Charanjit S. Rihal   +7 more
openalex   +1 more source

P3700Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary PCI in acute myocardial infarction of anterior location [PDF]

, 2017
F. J. Morales Ponce, F.J. Lozano Cid, P. Martinez Romero, P. González Pérez, J.A. Sánchez Brotons, I. Díaz Torres, Eduardo Martínez de Morentín, I. Perez Lopez, Francisco Javier Camacho Jurado, R González, P.L. Martinez Garcia, C. Collado Moreno, Sánchez Turrión, Philippe Matéo, Ana Serrador   +14 more
openalex   +1 more source